[Acute episode].
Schölmerich
J
J
Klinik für innere Medizin, Universitätsklinikum Regensburg.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D018849:Controlled Clinical Trials as Topic; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D019804:Mesalamine / Q000008:administration & dosage / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D009747:Nutritional Physiological Phenomena; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D019819:Budesonide; D011239:Prednisolone; D015122:Mercaptopurine; D001379:Azathioprine